Association between COVID-19 Severity and Expression of Viral Nucleic Acid Sensor Genes in Peripheral Blood Mononuclear Cells and Nasopharyngeal Epithelial Cells
The American Journal of Tropical Medicine and Hygiene · 2024
DOI: 10.4269/ajtmh.24-0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Zohreh-Al-Sadat Ghoreshi und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran. Hauptthemen laut MEDLINE: COVID-19, Leukocytes, Mononuclear, Epithelial Cells, Nasopharynx. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study examined expression of key viral nucleic acid sensor genes MDA5, ZBP1, and AIM2 in nasopharyngeal epithelial cells and peripheral blood mononuclear cells (PBMCs) obtained from 153 COVID-19 patients across a spectrum of disease severity (mild, severe, and critical) and 42 healthy controls. Quantitative reverse transcription polymerase chain reaction was used to quantify and compare sensor transcript levels. The COVID-19 cohort had a mean age of 53.6 years. All three sensor genes including MDA5 (3.2-fold), ZBP1 (5.1-fold), and AIM2 (4.7-fold) exhibited significantly higher messenger RNA expression in both nasopharyngeal and PBMC samples from infected patients compared with healthy controls. Furthermore, sensor transcript upregulation positively correlated with escalating disease severity. During early stages, ZBP1 and AIM2 transcripts were selectively elevated within the nasopharyngeal compartment, suggesting a localized antiviral response. Whereas later during critical disease stages, ZBP1 and AIM2 levels became preferentially heightened within circulating PBMCs, indicating systemic immune cell activation. By comparison, MDA5 elevation manifested within nasopharyngeal epithelial cells during both early- and late-phase infection. Intriguingly, males displayed higher ZBP1 and AIM2 expression compared with females, whereas MDA5 transcript levels were conversely higher among females. Overall, escalation of these key viral sensor genes appears closely linked to COVID-19 progression, with initial nasal mucosal upregulation transitioning to widespread blood cell activation in severe systemic disease. These patterns of sensor expression suggest frontline immunological efforts to constrain early viral invasion and combat severe late-stage COVID-19 illness through innate detection of replicating SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.
- Department of Basic Medical Sciences, Khoy University of Medical Sciences, Khoy, Iran.
- Student Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran.
- Bio Environmental Health Hazards Research Center, Jiroft University of Medical Sciences, Jiroft, Iran.
Zitieren
APA
Ghoreshi, Z. A., Behboudi, E., Askarpour, H., Raesi Nejad, F., & Arefinia, N. (2024). Association between COVID-19 Severity and Expression of Viral Nucleic Acid Sensor Genes in Peripheral Blood Mononuclear Cells and Nasopharyngeal Epithelial Cells. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.24-0004
Vancouver
Ghoreshi ZA, Behboudi E, Askarpour H, Raesi Nejad F, Arefinia N. Association between COVID-19 Severity and Expression of Viral Nucleic Acid Sensor Genes in Peripheral Blood Mononuclear Cells and Nasopharyngeal Epithelial Cells. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.24-0004
BibTeX
@article{Ghoreshi2024,
author = {Ghoreshi, Zohreh-Al-Sadat and Behboudi, Emad and Askarpour, Hedyeh and Raesi Nejad, Fatemeh and Arefinia, Nasir},
title = {Association between COVID-19 Severity and Expression of Viral Nucleic Acid Sensor Genes in Peripheral Blood Mononuclear Cells and Nasopharyngeal Epithelial Cells},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2024},
doi = {10.4269/ajtmh.24-0004}
}
EUVIMED